Press release
Duchenne Muscular Dystrophy Market Size (USD 2.1 billion by 2031) Achieves Record-breaking Growth in Meeting Healthcare Requirements
Duchenne Muscular Dystrophy
This report provides a comprehensive overview of the Duchenne Muscular Dystrophy Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the Duchenne Muscular Dystrophy Market and its growth potential in the future.
Rise in the incidence of the Duchenne muscular dystrophy (DMD) and surge in need for better healthcare services drive the growth of the global Duchenne muscular dystrophy market. However, inflated cost of treatments for Duchenne muscular dystrophy restricts the market growth. On the other hand, increase in government spending on the pharmaceutical and biotechnology sectors in developing countries, the development of healthcare infrastructure, and rise in demand for innovative treatments for Duchenne muscular dystrophy present new opportunities in the coming years.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/A15646
Top Companies Of Duchenne Muscular Dystrophy (DMD)
• F Hoffmann-La Roche AG
• FibroGen, Inc
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Nippon Shinyaku Co., Ltd
• Pfizer Inc.
• PTC Therapeutics
• Santhera Pharmaceuticals Inc
• Sarepta therapeutics
• Wave life sciences ltd.
• ABBOTT LABORATORIES
Duchenne Muscular Dystrophy (DMD) Market Size Segmentation: -
Based on therapeutic area, the molecular-based therapies segment held the highest market share in 2021, accounting for around three-fifths of the global Duchenne muscular dystrophy market, and is estimated to maintain its leadership status throughout the forecast period. In addition, the same segment is projected to manifest the highest CAGR of 5.0% from 2022 to 2031, owing to R & D activities for exon skipping drugs, strong product pipeline and significant product launch by key players. The report also discusses steroid therapy segment.
Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to more than three-fifths of the global Duchenne muscular dystrophy market, and is projected to maintain its lead position during the forecast period. This is owing to significant rise in the number of diagnosis through hospitals. However, the drug store & retail pharmacies segment is expected to portray the largest CAGR of 5.4% from 2022 to 2031, owing to the rise in the approval of drugs and their availability in drug store & retail pharmacies.
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than half of the global Duchenne muscular dystrophy market, and is likely to dominate the market during the forecast period. This is owing to technological advancements in Duchenne muscular dystrophy treatment and presence of key players & robust hospital infrastructure in the region.
However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2022 to 2031. This is owing to rise in cases of Duchenne muscular dystrophy, approval of drugs, development of healthcare infrastructure, and increase in investments projects in the region.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/16015
Key Benefits For Stakeholders
• The report provides an in-depth analysis of the Duchenne muscular dystrophy market size along with the current trends and future estimations to elucidate imminent investment pockets.
• It offers market analysis from 2022 to 2031, which is expected to enable stakeholders to capitalize on prevailing opportunities in the Duchenne muscular dystrophy market.
• A comprehensive analysis on region assists to understand the regional market, facilitate strategic business planning, and determine prevailing opportunities.
• The profiles and growth strategies of key players are thoroughly analyzed to understand competitive outlook of the global Duchenne muscular dystrophy treatment market growth.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Market Size (USD 2.1 billion by 2031) Achieves Record-breaking Growth in Meeting Healthcare Requirements here
News-ID: 3981149 • Views: …
More Releases from Allied Market Research (AMR)
Copper Smelting Market Future Trends and Scope Analysis Report
The global copper smelting market is witnessing steady growth, driven by the extensive adoption of advanced flash smelting processes, rising mining efficiency enabled by modern smelter technologies, and an increase in mining activities across various regions. Additionally, strong support from governmental organizations during the COVID-19 pandemic enabled copper smelting companies to expand production capacities, positively influencing overall market growth.
According to a report published by Allied Market Research, the global copper…
Calcium Citrate Market Exclusive Report on Current Trends and Future Insights
According to Allied Market Research, the global calcium citrate market was valued at $0.8 billion in 2021 and is projected to reach $1.2 billion by 2031, registering a CAGR of 3.7% from 2022 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17433
The study provides a comprehensive analysis of the market, featuring detailed company profiles, product portfolios, economic influences, and competitive positioning. The findings reveal that leading players are actively adopting strategic…
Petroleum Resins Market Growth and Restrain Factors Analysis Report
The global petroleum resins market is witnessing steady growth, driven by rising demand from the building and construction sector, increasing consumer awareness regarding baby hygiene products, and growing utilization of hydrogenated hydrocarbon resins in food packaging applications.
According to a report published by Allied Market Research, titled "Petroleum Resins Market by Resin Type, Application, and End-Use Industry: Global Opportunity Analysis and Industry Forecast, 2023-2028," the market was valued at $2.5 billion…
Biphenyl Market Report Latest Trends and Future Opportunities Analysis
Shifting consumer preferences toward packaged food products, coupled with rapid urbanization and rising demand for consumer goods, are significantly driving the growth of the global biphenyl market. Biphenyl is widely used across industries such as food & beverages, textiles, pharmaceuticals, and chemicals, supporting its expanding market footprint.
The global biphenyl market was valued at $1.24 billion in 2021 and is projected to reach $1.98 billion by 2031, registering a CAGR of…
More Releases for Duchenne
Duchenne Muscular Dystrophy (DMD) Market Growth in 2034
Market Overview
The Duchenne Muscular Dystrophy (DMD) Market is expanding rapidly as advances in genetic medicine, exon-skipping therapies, gene therapy platforms, and improved diagnostic capabilities reshape treatment options for this severe, progressive neuromuscular disorder.
DMD is caused by mutations in the dystrophin gene, leading to muscle degeneration beginning in early childhood. Growing awareness among clinicians and caregivers, widespread adoption of next-generation sequencing (NGS), and increasing availability of disease-modifying therapies have significantly strengthened…
Duchenne Muscular Dystrophy: Core Growth Enabler in the Rising Prevalence Of Chr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025?
The market size for Duchenne Muscular Dystrophy has shown significant expansion recently, burgeoning from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The impressive growth in the…
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be?
The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives.
The Duchenne muscular dystrophy (DMD) therapeutics…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period
The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
